Please provide your email address to receive an email when new articles are posted on . Data from more than 1.3 million admissions to teaching and nonteaching hospitals show there were no differences ...
Early use of sodium-glucose cotransporter 2 (SGLT2) inhibitors may improve outcomes among patients with type 2 diabetes undergoing PCI for an acute MI, a retrospective study indicates. Those started ...
An increase in the number of percutaneous coronary interventions does not appear to have resulted in reduced mortality rates, ...
ATLANTA -- Plasma-derived human apolipoprotein A1 (CSL112) infusions failed to improve outcomes for acute myocardial infarction (MI) patients with multivessel coronary artery disease and other ...
The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed. Patients with an acute myocardial infarction (MI) and a left ventricular ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. During the first year of the COVID-19 pandemic, ...
CHICAGO, IL—For patients with a history of acute MI who are vulnerable to the cardiovascular risks posed by influenza infection, email reminders can encourage them to get their annual jab, according ...
The authors collected resource utilization and cost of treatment data (in US dollars, excluding physicians' fees) from the cost accounting systems of two Canadian hospitals (n=215) and seven US ...
Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...
Acute myocardial infarction (AMI) continues to be a leading cause of death worldwide, necessitating rapid and accurate diagnosis to mitigate severe cardiac damage. The electrocardiogram (ECG) remains ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results